Rabeprazole 10 mg q.d.s. decreases 24-h intragastric acidity significantly more than rabeprazole 20 mg b.d. or 40 mg o.m., overcoming CYP2C19 genotype-Reference-Cited by-同舟云学术

Rabeprazole 10 mg q.d.s. decreases 24-h intragastric acidity significantly more than rabeprazole 20 mg b.d. or 40 mg o.m., overcoming CYP2C19 genotype

Published:2012-08-10 Issue:7 Volume:36 Page:627-634
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Sugimoto M.¹,Shirai N.²,Nishino M.²,Kodaira C.¹,Uotani T.¹,Yamade M.¹,Sahara S.¹,Ichikawa H.¹,Sugimoto K.¹,Miyajima H.¹,Furuta T.³

Affiliation:

1. First Department of Medicine; Hamamatsu University School of Medicine; Hamamatsu; Shizuoka; Japan

2. Department of Gastroenterology; Enshu General Hospital; Hamamatsu; Shizuoka; Japan

3. Center for Clinical Research; Hamamatsu University School of Medicine; Hamamatsu; Shizuoka; Japan

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.12014/fullpdf

Reference39 articles.

1. The treatment of Helicobacter pylori infection in the management of peptic ulcer disease;Walsh;N Engl J Med,1995

2. Influence of CYP2C19 polymorphism and Helicobacter pylori genotype determined from gastric tissue samples on response to triple therapy for H. pylori infection;Furuta;Clin Gastroenterol Hepatol,2005

3. Effect of cytochrome P4502C19 genotypic differences on cure rates for gastroesophageal reflux disease by lansoprazole;Furuta;Clin Pharmacol Ther,2002

4. Evidence that the degree and duration of acid suppression are related to Helicobacter pylori eradication by triple therapy;Sugimoto;Helicobacter,2007

5. Current trends in the pharmacotherapy for peptic ulcer disease;Hixson;Arch Intern Med,1992

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evolving Concepts in Helicobacter pylori Management;Gastroenterology;2024-02

2. Eradication rate and adherence with high‐dose amoxicillin and proton pump inhibitor as first‐line treatment for Helicobacter pylori infection: Experience from University Hospital in Chile;Helicobacter;2024-01

3. Efficacy and safety of high-dose ilaprazole-amoxicillin dual therapy for Helicobacter pylori eradication: a prospective, single-center, randomized trial;Frontiers in Pharmacology;2023-11-07

4. Comparing high-dose dual therapy with bismuth-containing quadruple therapy for the initial eradication of Helicobacter pylori infection on Hainan Island: A randomized, multicenter clinical trial;Clinics and Research in Hepatology and Gastroenterology;2023-05

5. Helicobacter pylori infection;Nature Reviews Disease Primers;2023-04-20